CLCGY logo

Clicks Group Limited (CLCGY) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Clicks Group Limited (CLCGY), 0 değerindeki bir Healthcare şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 15 Mar 2026
46/100 AI Puanı

Clicks Group Limited (CLCGY) Sağlık ve Boru Hattı Genel Bakışı

CEOBertina D. Engelbrecht B.Proc
Çalışanlar19729
MerkezCape Town, ZA
Halka Arz Yılı2010
SektörHealthcare

Clicks Group Limited is a South African health and beauty retailer and pharmaceutical distributor, operating through retail and distribution segments. With a network of approximately 840 stores and 620 in-store pharmacies, Clicks Group caters to the middle to upper-income markets, while UPD distributes pharmaceutical products to various healthcare providers.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 15 Mar 2026

Yatırım Tezi

Clicks Group Limited presents a compelling investment case due to its established market position in South Africa's health and beauty retail and pharmaceutical distribution sectors. The company's diversified revenue streams, stemming from both retail and wholesale operations, provide resilience against economic fluctuations. With a P/E ratio of 21.28 and a dividend yield of 3.05%, the company offers a blend of value and income. Key growth catalysts include expansion of its retail footprint and increasing demand for pharmaceutical products. Potential risks include regulatory changes in the healthcare sector and competition from other retailers and distributors. The company's beta of 0.23 suggests relatively low volatility compared to the broader market.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $4.04 billion, reflecting its significant presence in the South African market.
  • P/E ratio of 21.28, indicating a reasonable valuation relative to its earnings.
  • Profit margin of 6.3%, demonstrating its ability to generate profits from its operations.
  • Gross margin of 25.4%, reflecting the efficiency of its supply chain and pricing strategies.
  • Dividend yield of 3.05%, offering an attractive income stream for investors.

Rakipler & Benzerleri

Güçlü Yönler

  • Extensive retail network and distribution capabilities.
  • Established brand reputation and customer loyalty.
  • Diversified revenue streams from retail and distribution segments.
  • Strong financial performance and profitability.

Zayıflıklar

  • Concentration of operations in South Africa.
  • Exposure to regulatory changes in the healthcare sector.
  • Dependence on key suppliers for pharmaceutical products.
  • Potential for margin pressure from competition.

Katalizörler

  • Ongoing: Expansion of retail footprint in South Africa, increasing market share.
  • Ongoing: Growing demand for pharmaceutical products, boosting distribution revenue.
  • Ongoing: Strategic partnerships to expand product offerings and market reach.

Riskler

  • Potential: Economic downturn in South Africa, impacting consumer spending.
  • Potential: Changes in government regulations and healthcare policies.
  • Potential: Increased competition from other retailers and distributors.
  • Ongoing: Fluctuations in currency exchange rates, affecting ADR value.

Büyüme Fırsatları

  • Expansion of Retail Footprint: Clicks Group can continue to expand its retail footprint by opening new stores in underserved areas and increasing the number of in-store pharmacies. This expansion will allow the company to reach a wider customer base and increase its market share. The South African retail market is expected to grow at a rate of 5% annually, providing a favorable environment for expansion. Timeline: Ongoing.
  • Increased Demand for Pharmaceutical Products: The demand for pharmaceutical products is expected to increase due to an aging population and rising healthcare awareness. Clicks Group, through its UPD distribution segment, is well-positioned to capitalize on this trend. The South African pharmaceutical market is projected to reach $10 billion by 2028. Timeline: Ongoing.
  • Growth in Specialty Health and Wellness Products: Clicks Group can further expand its offerings in specialty health and wellness products, such as vitamins, mineral supplements, and sports nutrition. This will cater to the growing demand for preventative healthcare and wellness products. The global wellness market is estimated to be worth over $1.5 trillion. Timeline: Ongoing.
  • E-commerce Expansion: Clicks Group can invest in its e-commerce platform to reach customers beyond its physical store network. This will allow the company to compete with online retailers and cater to the growing demand for online shopping. The South African e-commerce market is expected to grow at a rate of 15% annually. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Clicks Group can pursue strategic partnerships and acquisitions to expand its product offerings and market reach. This could include partnerships with other healthcare providers or acquisitions of smaller retail chains or pharmaceutical distributors. Timeline: Ongoing.

Fırsatlar

  • Expansion into new geographic markets.
  • Growth in specialty health and wellness products.
  • Increased demand for pharmaceutical products.
  • E-commerce expansion and digital transformation.

Tehditler

  • Economic downturn in South Africa.
  • Increased competition from other retailers and distributors.
  • Changes in government regulations and healthcare policies.
  • Fluctuations in currency exchange rates.

Rekabet Avantajları

  • Extensive retail network of approximately 840 stores and 620 in-store pharmacies.
  • Established brand reputation in the South African market.
  • Integrated business model encompassing both retail and distribution.
  • Strong relationships with pharmaceutical suppliers.

CLCGY Hakkında

Founded in 1968 and headquartered in Cape Town, South Africa, Clicks Group Limited has evolved into a prominent player in the health and beauty retail and pharmaceutical distribution sectors. Initially known as New Clicks Holdings Limited, the company rebranded as Clicks Group Limited in 2009. The company operates through two primary segments: Retail and Distribution. The Retail segment focuses on pharmacy, health, and beauty products, primarily targeting the middle to upper-income markets through its Clicks-branded stores. In addition to its core Clicks stores, the company also retails specialty health and wellness products under the General Nutrition Corporation (GNC) banner, luxury toiletries and cosmetics through The Body Shop, and fashion accessories via Claire's. The Distribution segment, operating under the UPD name, is involved in the wholesale and supply of pharmaceutical products to a diverse range of customers, including retail pharmacies, private hospitals, dispensing doctors, and retail health stores. Clicks Group's extensive network comprises approximately 840 stores and 620 in-store pharmacies across South Africa.

Ne Yaparlar

  • Operates as a health and beauty retailer in South Africa.
  • Distributes pharmaceutical products to retail pharmacies, hospitals, and doctors.
  • Retails pharmacy, health, and beauty products through Clicks stores.
  • Sells specialty health and wellness products under the GNC brand.
  • Offers luxury toiletries and cosmetics under The Body Shop brand.
  • Provides fashionable jewelry and accessories through Claire's stores.

İş Modeli

  • Retails health, beauty, and pharmaceutical products directly to consumers through its store network.
  • Distributes pharmaceutical products wholesale to healthcare providers.
  • Generates revenue through product sales in both retail and distribution segments.
  • Focuses on middle to upper-income markets in South Africa.

Sektör Bağlamı

Clicks Group Limited operates within the healthcare sector, specifically in the medical pharmaceuticals and retail pharmacy industries. The South African retail pharmacy market is characterized by increasing demand for healthcare products and services, driven by an aging population and rising healthcare awareness. The competitive landscape includes other retail chains, independent pharmacies, and pharmaceutical distributors. Clicks Group's integrated business model, encompassing both retail and distribution, provides a competitive advantage in this market. The company's extensive store network and established brand reputation further solidify its position.

Kilit Müşteriler

  • Individual consumers seeking health, beauty, and pharmaceutical products.
  • Retail pharmacies requiring pharmaceutical supplies.
  • Private hospitals needing pharmaceutical products.
  • Dispensing doctors requiring pharmaceutical supplies.
AI Güveni: 71% Güncellendi: 15 Mar 2026

Finansallar

Grafik & Bilgi

Clicks Group Limited (CLCGY) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

CLCGY için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

CLCGY için Wall Street fiyat hedefi analizi.

MoonshotScore

46/100

Bu puan ne anlama geliyor?

MoonshotScore, CLCGY'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Bertina D. Engelbrecht B.Proc

CEO

Bertina Engelbrecht holds a B.Proc degree and has extensive experience in the retail and healthcare sectors. She has been with Clicks Group Limited for several years, holding various leadership positions before being appointed as CEO. Her background includes expertise in strategic planning, operations management, and business development. She has a proven track record of driving growth and improving operational efficiency.

Sicil: Since becoming CEO, Bertina Engelbrecht has focused on expanding Clicks Group's retail footprint, enhancing its e-commerce capabilities, and strengthening its relationships with key suppliers. She has also overseen the implementation of several initiatives aimed at improving customer service and operational efficiency. Under her leadership, the company has maintained its strong financial performance and market position.

Clicks Group Limited ADR Bilgileri Sponsorsuz

An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that trades on U.S. stock exchanges. CLCGY is an ADR, meaning it allows U.S. investors to invest in Clicks Group Limited without directly dealing with foreign markets. Each CLCGY ADR represents a specific number of Clicks Group Limited's ordinary shares traded on its home market.

  • Ana Piyasa Sembolü: Johannesburg Stock Exchange (JSE) in South Africa.
  • ADR Seviyesi: 1
  • ADR Oranı: 1:1
  • Ana Piyasa Sembolü: CLCG
Kur Riski: As an ADR, CLCGY is subject to currency risk. The value of the ADR in U.S. dollars can be affected by fluctuations in the exchange rate between the U.S. dollar and the South African Rand. A weakening Rand can negatively impact the value of CLCGY for U.S. investors, even if the underlying stock performs well in its home market.
Vergi Etkileri: Dividends paid on CLCGY ADRs may be subject to foreign dividend withholding tax in South Africa. The standard withholding tax rate is 20%. However, the U.S. has a tax treaty with South Africa that may reduce the withholding tax rate for eligible U.S. investors. It is important to consult with a tax advisor to determine the specific tax implications.
İşlem Saatleri: The Johannesburg Stock Exchange (JSE) operates from 9:00 AM to 5:00 PM South African time (GMT+2). This translates to 3:00 AM to 11:00 AM Eastern Time (ET) during standard time and 2:00 AM to 10:00 AM ET during daylight saving time. Therefore, there is a significant overlap in trading hours between the JSE and the U.S. OTC market, but U.S. investors should be aware of the time difference when trading CLCGY.

CLCGY OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited or no financial disclosure requirements and may not meet the listing standards of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of transparency and regulatory oversight compared to exchange-listed companies. This tier is also known for having the least liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: As an OTC-traded stock, CLCGY may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. Investors should be aware of the potential for illiquidity when trading CLCGY on the OTC market.
OTC Risk Faktörleri:
  • Limited financial disclosure and transparency.
  • Lower trading volume and liquidity.
  • Wider bid-ask spreads.
  • Potential for price volatility.
  • Increased risk of fraud or manipulation.
Durum Tespiti Kontrol Listesi:
  • Verify the company's registration and legal status.
  • Investigate the company's management team and their track record.
  • Assess the availability and quality of financial information.
  • Review the company's business model and competitive landscape.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal proceedings against the company.
Meşruiyet Sinyalleri:
  • Established business operations in South Africa.
  • Presence of a recognized brand (Clicks).
  • Availability of some company information (though disclosure level is unknown).
  • ADR structure allowing U.S. investment.

CLCGY Healthcare Hisse Senedi SSS

CLCGY için değerlendirilmesi gereken temel faktörler nelerdir?

Clicks Group Limited (CLCGY) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Extensive retail network and distribution capabilities.. İzlenmesi gereken birincil risk: Potential: Economic downturn in South Africa, impacting consumer spending.. Bu bir finansal tavsiye değildir.

CLCGY MoonshotScore'u nedir?

CLCGY şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

CLCGY verileri ne sıklıkla güncellenir?

CLCGY fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler CLCGY hakkında ne diyor?

CLCGY için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

CLCGY'a yatırım yapmanın riskleri nelerdir?

CLCGY için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturn in South Africa, impacting consumer spending.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

CLCGY'ın P/E oranı nedir?

CLCGY için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için CLCGY'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

CLCGY aşırı değerli mi, yoksa düşük değerli mi?

Clicks Group Limited (CLCGY)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

CLCGY'ın temettü verimi nedir?

Clicks Group Limited (CLCGY) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited analyst coverage due to OTC listing.
  • Disclosure status on OTC market is unknown.
Veri Kaynakları

Popüler Hisseler